With the fiscal year (FY) 2026 ICD-10-CM updates/changes revision incorporating 487 new diagnosis codes, inpatient coders will have the capability to report conditions with enhanced precision in domains such as wound care, ophthalmology, neurology, nephrology, pathology, and chronic disease coding. These codes will be accessible for utilization starting October 1, 2025.
Non-pressure chronic ulcers- 2026 ICD-10-CM updates/changes
A significant enhancement has taken place in the coding of non-pressure ulcers, which will now be assigned their own dedicated subcategories, L98.4- and L98. A-, encompassing over 100 new codes. Previously, these ulcers were inconsistently classified within various skin or vascular disease categories. The updated codes differentiate ulcers based on anatomical location, laterality, and depth or severity (e.g., fat layer exposure, necrosis of muscle or bone, involvement of muscle or bone). This distinction is particularly pertinent in cases involving systemic conditions such as diabetes, vascular disease, or immunocompromised states, where wound healing is compromised.
Examples of codes include:
L98.431, non-pressure chronic ulcer of abdomen limited to breakdown of skin
L98.452, non-pressure chronic ulcer of neck with fat layer exposed
L98.A314, non-pressure chronic ulcer of right hand with necrosis of bone
For patients undergoing wound care or surgical procedures, enhanced coding specificity bolsters DRG capture and clinical accuracy.
Expanded signs of pain and tenderness
Significant advancements have been made in the classification of pelvic, abdominal, and flank pain and tenderness, which are common reasons for inpatient and emergency admissions. Code R10.2 (pelvic and perineal pain) has been revised and expanded into new, laterality-specific codes: R10.21 for pain on the right side, R10.22 for pain on the left side, and R10.23 for bilateral pain. Additional codes for suprapubic pain and tenderness, abdominal pain, flank pain and tenderness, and costovertebral tenderness have been introduced, facilitating more precise symptom coding in patients assessed for urologic, gynecologic, or abdominal conditions. These modifications mitigate ambiguity and help align symptom coding with the condition’s anatomical location and suspected source of pathology.
Metabolic disorders and deficiencies- 2026 ICD-10-CM updates/changes
The update includes several additions to enhance the capacity to document rare, hereditary, and therapeutically impactful metabolic disorders. One of the most noteworthy is primary hyperoxaluria, a rare genetic condition that results in excess oxalate production and significant renal impairment. Previously classified under a general code, hyperoxaluria is now segmented into two primary subcategories with various subtypes: subcategory E72.53- for primary hyperoxaluria encompasses type 1 (E72.530) and subcategory E72.54- for secondary hyperoxaluria includes dietary (E72.540) and enteric (E72.541).
In a similar vein, coders can now differentiate diverse forms of familial hypercholesterolemia (FH). The revised codes E78.010 (homozygous FH) and E78.11 (heterozygous FH) enable more specific distinctions between types of FH, which is particularly beneficial in cardiology and stroke admissions where inherited lipid disorders may contribute to early atherosclerosis, coronary artery disease, or statin-resistant hyperlipidemia.
Additionally noteworthy is the introduction of more codes for lipodystrophy not elsewhere classified, allowing inpatient coders to capture this rare yet increasingly acknowledged condition characterized by abnormal fat distribution and metabolic complications. Under subcategory E88.1, lipodystrophy is categorized into different types, including partial (E88.11), generalized (E88.12), localized (E88.13), HIV-associated (E88.14), and other (E88.19).
Further enhancing this section are novel codes for genetically characterized deficiencies including ENPP1 (E83.821 or E83.822), ABCC6 (E83.823 or E83.824), and CD73 (E83.825). These newly introduced codes enable coders to accurately record these diagnoses when they appear in genetic testing reports or metabolic consultation notes, particularly in cases where patients manifest nephrocalcinosis, arterial ischemia, or multisystem calcification disorders.
MUST BUY ICD-10 CM CODING EBOOKS
Eyelid Conditions- 2026 ICD-10-CM updates/changes
Advancements in ophthalmological coding have also been significant. To enhance specificity in documenting ocular infections, post-surgical inflammations, cellulitis, or allergic responses during hospital admissions, code H01.8 (other specified inflammations of eyelid) has been supplanted by nine new codes that distinguish between the upper and lower eyelid, as well as the right and left eye. Moreover, a new subcategory under H05.8- (other disorders of orbit) has been established, incorporating four newly created codes for thyroid orbitopathy (H05.83-), commonly referred to as thyroid eye disease, which may occur in conjunction with Graves’ disease or other thyroid disorders. Additionally, new codes for neovascular secondary angle-closure glaucoma (H40.84-) empower coders to report laterality-specific instances of glaucoma frequently associated with diabetic retinopathy, retinal vein occlusion, or ocular ischemic syndrome. These codes will be incorporated into a new subcategory under H40.8 (other glaucoma).
Multiple Sclerosis Subtypes – 2026 ICD-10-CM updates/changes
The revision to code G35 for multiple sclerosis (MS) marks a significant advancement in neurology coding. The original single MS code has now been segmented into multiple new codes that classify subtypes of the condition, including relapsing-remitting MS, active primary and secondary progressive MS, and non-active forms, with the option to indicate whether the disease is in an active or inactive state. This modification is particularly pertinent for inpatient coders responsible for managing documentation related to neurology consultations, imaging outcomes, or symptom exacerbations, as the specific subtype can influence treatment and prognosis. Coders should be vigilant for documentation that specifies the type of MS and its activity status to ensure the most accurate code assignment.
Kidney Disease and Genetic Nephropathies-2026 ICD-10-CM updates/changes
New codes have been included under N00. B- and N04. B- for idiopathic and secondary immune membranoproliferative glomerulonephritis (IC-MPGN), as well as a code for hereditary nephropathy (N07. B). These modifications are vital for the precise coding of inpatient nephrology cases, particularly those involving intricate renal biopsy results, genetic counseling, or the progression of chronic kidney disease. Coders may encounter these terms within nephrologist documentation or pathology reports.
Toxicity, Adverse Effects, and Underdosing- 2026 ICD-10-CM updates/changes
This update introduces a new array of T36. A- codes to document fluoroquinolone antibiotic toxicity and T65.8- codes to identify xylazine toxicity. These codes clarify the nature of exposure (e.g., accidental, intentional self-harm, assault, adverse effect, and underdosing) and necessitate a seventh character to describe the type of encounter. This level of detail is increasingly critical for inpatient admissions where drug-induced complications such as tendon rupture, QT prolongation, or neurotoxicity could necessitate consultations or modifications in treatment. Coders should meticulously examine documentation regarding medication history and the context of symptoms to facilitate accurate classification of these events.
Coders can now assign unique anaphylaxis codes for reactions to milk and dairy products or egg-related items within the expanded T78.070A-T78.08XS subcategories. In addition to anaphylaxis, newly introduced codes address other adverse food reactions (non-anaphylactic) related to milk and dairy (T78.11-) and eggs (T78.12-). These codes are applicable in instances where a patient experiences symptoms such as nausea, vomiting, urticaria, or respiratory difficulties due to a food allergy, but without the full systemic response characteristic of anaphylaxis.
Factors Influencing Health (Z-Codes)
Acknowledging the increasing clinical significance of social risk factors, the 2026 code set augments the Z55-Z65 categories pertaining to social determinants of health. The introduction of new codes facilitates more accurate documentation of financial instability, with Z59.86 designated as a parent code. Additional codes delineate encounters for other prophylactic surgeries, exposure to conflict zones, familial history of kidney and ureter disorders, and allergies to milk or eggs. These codes hold substantial value for inpatient discharge planning, care coordination, and social work consultations, potentially impacting risk-adjusted quality metrics and resource allocation.
Other Notable Updates
Several further diagnostic codes reflect revisions across a range of specialties. The inclusion of R11.16 now identifies cannabinoid hyperemesis syndrome, a condition increasingly acknowledged among frequent cannabis users presenting with nausea, vomiting, and abdominal distress. A newly established code, R76.89, captures unspecified elevated immunological markers, advantageous for documenting abnormal laboratory findings during autoimmune disease assessments. Oncology updates encompass expanded codes for inflammatory breast conditions (subcategory C50. A-) and genetic predisposition codes for colorectal cancer (Z15.060) as well as digestive system malignancies (Z15.068). Hematology codes have been refined to more accurately identify disorders related to neutrophils (subcategory D71.-) as well.
While these codes are limited in quantity, their specificity is substantial, aiding inpatient coders in aligning documentation from various specialties.